This is a new investigator R01 application, in response to the Program Announcement (PA-04-158) for Ancillary Studies to the Alzheimer's Disease Neuroimaging Initiative. There is a critical need for biomarkers that can detect a """"""""signal of efficacy"""""""" in early phase clinical trials of promising disease modifying therapies for Alzheimer's disease (AD). Functional magnetic resonance imaging (fMRI) has considerable potential as a marker of acute pharmacological effects in """"""""Proof of Concept"""""""" AD trials and as a marker of very mild cognitive impairment (MCI) in longitudinal studies of clinical progression. Our previous fMRI studies, using a face-name associative memory paradigm, have demonstrated regionally specific pharmacological effects on memory related activation in young subjects, and significant differences in the pattern of fMRI activation between normal older controls, MCI subjects and mild AD patients. In order to further validate fMRI as a potential biomarker, we will examine test-retest reliability, cross-scanner platform reproducibility, and relate fMRI activation to clinical status cross-sectionally and longitudinally in older normal controls, MCI and mild AD subjects. We will also elucidate the factors contributing to alterations in fMRI activation using advances in fMRI and other MR techniques, including 1) mixed block/event-related subsequent memory paradigms to isolate the neural correlates of successful vs. failed memory processes, 2) arterial spin labeling (ASL) perfusion MRI to examine resting cerebral blood flow and 3) high resolution structural MRI to measure atrophy. The proposed study will take place across two sites in Boston and will utilize subject selection criteria, assessment instruments, and visit timing from the main ADNI study, with minor modifications to take full advantage of fMRI capabilities. We hypothesize that memory related fMRI activation is a sensitive marker of synaptic dysfunction due to early AD pathology that will precede atrophy and alterations in resting perfusion. The proposed research will provide essential validation studies for fMRI as a biomarker in AD clinical trials, and enhance our fundamental understanding of the early pathophysiological alterations in AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG027435-03
Application #
7365079
Study Section
Clinical Neuroscience and Disease Study Section (CND)
Program Officer
Hsiao, John
Project Start
2006-05-01
Project End
2011-01-31
Budget Start
2008-03-01
Budget End
2009-01-31
Support Year
3
Fiscal Year
2008
Total Cost
$1,171,848
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Hanseeuw, Bernard J; Jonas, Victoria; Jackson, Jonathan et al. (2018) Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry :
Jacobs, Heidi I L; Hedden, Trey; Schultz, Aaron P et al. (2018) Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci 21:424-431
d'Oleire Uquillas, Federico; Jacobs, Heidi I L; Hanseeuw, Bernard et al. (2018) Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals. Neuroimage Clin 17:388-396
Sanabria, Angela; Alegret, Montserrat; Rodriguez-Gomez, Octavio et al. (2018) The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline. Sci Rep 8:3828
Buckley, Rachel F; Mormino, Elizabeth C; Amariglio, Rebecca E et al. (2018) Sex, amyloid, and APOE ?4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimers Dement 14:1193-1203
Lois, Cristina; Gonzalez, Ivan; Johnson, Keith A et al. (2018) PET imaging of tau protein targets: a methodology perspective. Brain Imaging Behav :
Donovan, Nancy J; Locascio, Joseph J; Marshall, Gad A et al. (2018) Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. Am J Psychiatry 175:530-537
Vannini, Patrizia; Hanseeuw, Bernard; Munro, Catherine E et al. (2017) Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. Neuroimage Clin 15:408-414
Rentz, Dorene M; Weiss, Blair K; Jacobs, Emily G et al. (2017) Sex differences in episodic memory in early midlife: impact of reproductive aging. Menopause 24:400-408
LaPoint, Molly R; Chhatwal, Jasmeer P; Sepulcre, Jorge et al. (2017) The association between tau PET and retrospective cortical thinning in clinically normal elderly. Neuroimage 157:612-622

Showing the most recent 10 out of 114 publications